It would not be an exaggeration to say that COVID-19 vaccines are the most sought-after commodity today. Vaccine producers are working overtime to produce enough vaccine doses to fulfill government commitments and timelines. While pharmaceutical companies stepped up their production schedules to develop and test vaccines, adversaries tracked the news and devised campaigns to leverage the momentum generated by news coverage. They capitalize on the fear, uncertainty, and doubt (FUD) of people to spread misinformation and to plan attack vectors. Fake websites are purporting to offer (mis)information about vaccine distribution. There are attacks on vaccine supply chains and networks of pharma companies too.
Some of these attacks on pharma companies originate from mixed motivations. Some adversaries launch cyberattacks for financial gains – to steal and sell vaccine-related information or clinical trial data, while others are directed to disrupt vaccine production.
The April 2021 issue of CISO MAG focuses on the types of attack vectors on pharma companies and consumers. Security experts from various organizations offer solid evidence and testimonials – with advice to contain these attacks.